Blepharoptosis onset after topical prostaglandin therapy for glaucoma

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 1442-6404, Iss. 7, 2015-09 ,pp. : 689-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy

By Denis Ph.   Lafuma A.   Khoshnood B.   Mimaud V.   Berdeaux G.  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 601-608

Informa Healthcare

Access to resources Recommend Favorite

Physicians’ treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma

By Hahn Steven R.   Kotak Sameer   Tan Jason   Kim Elizabeth  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients: A Canadian Population-Based Analysis

By Iskedjian Michael  

The Patient: Patient-Centered Outcomes Research, Vol. 4, Iss. 2, 2011-06 ,pp. : 133-141

Adis International

Access to resources Recommend Favorite

Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective

By Schmier Jordana K.   Covert David W.   Robin Alan L.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2867-2875

Informa Healthcare

Access to resources Recommend Favorite